At 8AM IST, SGX Nifty was up 15 points at 5,985.
According to the technical charts “We could see some more upside in the near term, and the Nifty may look to stretch the rally to 6,100-odd levels. However, failure to sustain above 6,000-mark can trigger profit taking and the index can slip to near about 5,900-level. ”.
Also Read
Bernanke is set to testify to Congress on Wednesday and Thursday, which could provide further clarity on when the US central bank will roll back its $85 billion a month bond-buying programme.
Among the key Asian indices, Japan’s Nikkei was down 0.7% to 14,489 in the opening deals.
Overnight, US stocks retreated after eight day of gains.
The Dow Jones industrial average slipped 32.41 points, or 0.21 percent, to end at 15,451.85. The Standard & Poor's 500 Index declined 6.24 points, or 0.37 percent, to finish at 1,676.26. The Nasdaq Composite Index fell 8.99 points, or 0.25 percent, to close at 3,598.50.
Following stocks are expected to move on the exchanges today:
Pharmaceutical companies are gearing up to challenge the Centre’s populist move to slash prices of essential medicines through the new drug pricing policy. According to sources, drug makers Cipla and Alembic have approached the Delhi High Court and Gujarat High Court, respectively, challenging the provisions of the new Drug Price Control Order (DPCO), 2013, notified by the government in May.
State-owned miner Coal India Ltd (CIL), which plans to invest Rs 6,000 crore in foreign acquisitions in FY14, is evaluating buying stakes in three coal assets in Australia to bridge the shortfall in its domestic production, sources said.
DCB Bank said its net profit for the quarter ended June 30 increased to Rs 43 crore from Rs 19 crore a year ago, aided by higher interest income and increase in non-interest income.
.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)